Micellar droplets and nanoemulsions in respiratory and formulation contexts (MD/NE)

Micellar droplets and nanoemulsions are advanced colloidal drug delivery systems utilized to improve the therapeutic index of poorly water-soluble drugs, particularly in respiratory medicine. Micelles are self-assembled spherical structures formed by amphiphilic molecules, while nanoemulsions are kinetically stable dispersions of oil and water stabilized by surfactants, typically with droplet sizes ranging from 10 to 200 nm. In the context of respiratory formulation, these systems are designed to overcome physiological barriers such as the thick mucus found in cystic fibrosis or chronic obstructive pulmonary disease (COPD), allowing for deeper lung penetration and sustained drug release. While they are not biological targets themselves, they are critical tools in pharmacology for modulating the pharmacokinetics and biodistribution of various anti-inflammatory, antimicrobial, and anticancer agents. Their development focuses on biocompatibility, aerosolization efficiency, and the ability to bypass or utilize the lung's natural clearance mechanisms.

Other names

MicellesNanoemulsionsLipid-based nanocarriersColloidal drug delivery systemsSurfactant-based droplets

These systems function as drug delivery vehicles that enhance the solubility of hydrophobic compounds, protect active pharmaceutical ingredients from enzymatic degradation, and facilitate penetration through biological barriers such as the respiratory mucus layer. In respiratory contexts, they improve the deposition and retention of inhaled drugs within the lungs by optimizing droplet size and surface properties.